Kendall Capital Management’s JPMorgan Chase JPM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$459K Sell
1,562
-51
-3% -$15.5K 0.09% 165
2025
Q4
$520K Buy
1,613
+115
+8% +$35.6K 0.11% 155
2025
Q3
$473K Sell
1,498
-136
-8% -$40.4K 0.11% 162
2025
Q2
$474K Buy
1,634
+73
+5% +$18.6K 0.13% 152
2025
Q1
$383K Hold
1,561
0.11% 161
2024
Q4
$374K Sell
1,561
-35
-2% -$8.15K 0.11% 165
2024
Q3
$337K Hold
1,596
0.1% 177
2024
Q2
$323K Hold
1,596
0.11% 168
2024
Q1
$320K Hold
1,596
0.11% 169
2023
Q4
$271K Hold
1,596
0.11% 177
2023
Q3
$231K Hold
1,596
0.1% 177
2023
Q2
$232K Hold
1,596
0.1% 180
2023
Q1
$208K Sell
1,596
-26
-2% -$3.56K 0.1% 178
2022
Q4
$218K Buy
+1,622
New +$206K 0.11% 168
2022
Q1
Sell
-1,406
Closed -$223K 164
2021
Q4
$223K Buy
1,406
+100
+8% +$16.4K 0.11% 158
2021
Q3
$214K Buy
+1,306
New +$205K 0.12% 148

Other funds holding JPM

Kendall Capital Management's JPM Position: Q1 2026 in Review

Kendall Capital Management reduced its JPMorgan Chase (JPM) stake by 3.2% in Q1 2026, selling an estimated $15.5K and leaving 1,562 shares worth $459K. The position accounts for 0.09% of the portfolio, ranked #165.

Kendall Capital Management first reported a position in JPM in Q3 2021 and has held it in 16 quarters since. The position peaked at $520K in Q4 2025. 5,053 funds tracked by Wall St. Rank hold JPM as of Q1 2026.

  • Kendall Capital Management held 1,562 shares of JPMorgan Chase worth $459K as of Q1 2026.
  • Kendall Capital Management sold 51 JPMorgan Chase shares in Q1 2026, an estimated $15.5K.
  • JPMorgan Chase made up 0.09% of Kendall Capital Management's portfolio in Q1 2026, its #165 holding.
  • Kendall Capital Management first reported a position in JPMorgan Chase in Q3 2021 and has held it in 16 quarters since.
  • Kendall Capital Management's JPMorgan Chase position peaked at $520K in Q4 2025.
  • 5,053 funds tracked by Wall St. Rank held JPMorgan Chase as of Q1 2026.

Based on Kendall Capital Management's 13F filing for Q1 2026, filed 24 Apr 2026.